Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Penneo - Presentation of Half-Year report 2022 24.08.2022

By HC Andersen Capital
Penneo

Penneo is expected to announce its half-year results for 2022 on Wednesday the 24 August 2022. On the same day at 2:00 PM, you can meet and ask questions to the company’s CEO Christian Stendevad, and CFO Casper Christiansen, who will present the results in a virtual live event.

The recent development in SaaS metrics is expected to draw attention, including the recent churn rate and uplift. In particular, the uplift from Penneo’s KYC solution will be interesting since the company in Q1 2022 reprioritized parts of the sales organization from focusing on newbizz on its Sign solution to upselling its KYC solution. Additionally, an update on the ARR development in foreign markets will shed light on Penneo’s execution of the expansion strategy. The company completed a private placement earlier this year, resulting in net proceeds of DKK 59 million. As a result, Penneo now has financial flexibility and expects to intensify investments in long-term ARR growth. In the Q1 2022 report, this led to a downgrade in EBITDA expectations for the full-year 2022 from the interval DKK -10 million to -5 million to the interval DKK -20 million to -15 million. ARR guidance of DKK 77-82 million at the end of 2022 (40-49% growth) was maintained. HC Andersen Capital receives payment for a Corporate Visibility/Digital IR subscription agreement from Penneo. /Kasper Lihn 9.57 AM 20/7-2022

Recent videos

Life Science Companies as Investments | Life Science Night Dec. 9, 2025
2025-12-16 08:30 Aiforia Technologies
Truecaller, Webcast, Press Conference, 2025
2025-12-15 13:00 Truecaller
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
2025-12-15 13:00 Herantis Pharma
Orion as an Investment | Life Science Night Dec. 9, 2025
2025-12-13 12:50 Orion
A sit-down with CEO Remco Westermann
2025-12-12 09:09 Verve Group
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.